K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy
about
Can K-ras gene mutation be utilized as prognostic biomarker for colorectal cancer patients receiving chemotherapy? A meta-analysis and systematic reviewEstablishment and characterization of cell lines from chromosomal instable colorectal cancer.Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer.The multi-hit hypothesis in basal-like breast cancer.Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells.
P2860
K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
K-Ras gene mutation status as ...... oxaliplatin-based chemotherapy
@ast
K-Ras gene mutation status as ...... oxaliplatin-based chemotherapy
@en
type
label
K-Ras gene mutation status as ...... oxaliplatin-based chemotherapy
@ast
K-Ras gene mutation status as ...... oxaliplatin-based chemotherapy
@en
prefLabel
K-Ras gene mutation status as ...... oxaliplatin-based chemotherapy
@ast
K-Ras gene mutation status as ...... oxaliplatin-based chemotherapy
@en
P2093
P2860
P356
P1476
K-Ras gene mutation status as ...... oxaliplatin-based chemotherapy
@en
P2093
Cezary Szczylik
Jacek Nikliński
Jan Korniluk
Lech Chyczewski
Lubomir Bodnar
Marta Rokita
Marta Smoter
Marzena Ciechowicz
Radosław Charkiewicz
Wojciech Kozłowski
P2860
P304
P356
10.4161/CBT.21813
P50
P577
2012-08-22T00:00:00Z